Ameresco, Lithium Americas, Kodiak Sciences, and Other Major Stocks Rise on Thursday
U.S. Stock Market Overview: U.S. stocks declined, with the Nasdaq Composite dropping over 100 points on Thursday, while several individual stocks saw significant gains.
Ameresco Stock Surge: Ameresco, Inc. shares rose 10.5% to $34.94 after Jefferies upgraded the stock from Hold to Buy and increased its price target from $19 to $39.
Notable Stock Performances: Lithium Americas Corp. and Kodiak Sciences Inc. experienced substantial increases of 16.8% and 16%, respectively, due to positive news and analyst upgrades.
Other Gainers: Several other companies, including Centrus Energy Corp. and NioCorp Developments Ltd., also saw notable stock price increases, reflecting a generally positive trend for select stocks despite the overall market decline.
Trade with 70% Backtested Accuracy
Analyst Views on VERI
About VERI
About the author

- Lawsuit Background: A class action lawsuit has been filed on behalf of investors who purchased Veritone securities between October 14, 2025, and April 14, 2026, alleging inaccuracies in revenue and cost reporting that inflated financial statements, undermining investor confidence.
- Financial Impact: Veritone's preliminary financial results released on March 26, 2026, projected revenue between $18.1 million and $30 million, with shares plummeting approximately 30% in one day from $2.61 to $1.84, reflecting market concerns over the company's financial transparency.
- Audit Delays: In a Form NT 10-K filed on April 1, 2026, the company disclosed its inability to timely finalize certain revenue transactions, potentially necessitating revisions to financial statements for June and September 2025, exacerbating investor anxiety.
- Error Disclosure: On April 14, 2026, Veritone acknowledged errors in its previously issued financial statements, resulting in a $2.48 million (8.53%) reduction in quarterly revenue, causing shares to drop about 8.3% from $2.28 to $2.09, indicating a significant trust crisis for the company.
- Class Action Notice: Rosen Law Firm reminds investors who purchased Veritone securities between October 14, 2025, and April 14, 2026, to apply as lead plaintiffs by July 20, 2026, to potentially receive compensation without any out-of-pocket costs.
- Lawsuit Background: The lawsuit alleges that Veritone made false statements and failed to disclose critical information regarding its financial reporting, resulting in inflated revenue and assets, which caused investor losses and highlighted deficiencies in internal controls.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest settlement against a Chinese company, being ranked No. 1 by ISS Securities Class Action Services in 2017, indicating its expertise and success in this field.
- Investor Action Advice: Investors can visit the Rosen Law Firm website or call the toll-free number for more information, emphasizing the importance of selecting qualified legal counsel to protect their rights and avoid inexperienced intermediaries.
- Lawsuit Background: Veritone, Inc. is facing a securities class action lawsuit after admitting that its previously filed financial statements should no longer be relied upon, involving investors who purchased securities between October 14, 2025, and April 14, 2026, indicating severe issues with the company's financial transparency that could undermine investor confidence.
- Stock Price Volatility: Since March 26, 2026, Veritone's stock price has significantly declined due to a series of financial disclosure issues, with an announcement on April 14 causing an additional drop of over 8%, reflecting market concerns regarding the company's financial health.
- Financial Misconduct: The lawsuit alleges that Veritone failed to accurately record and classify certain revenues and costs, leading to overstated revenues and assets, which could trigger broader regulatory investigations and impact the company's reputation and future financing capabilities.
- Investor Losses: Hagens Berman is investigating whether Veritone intentionally misled investors, encouraging those who suffered substantial losses to submit claims, which could expose the company to higher legal and financial risks.
- Phreesia Lawsuit: Phreesia Inc. is accused of misleading investors from May 8, 2025, to March 30, 2026, by claiming reliable long-term growth prospects, while the uncertainty of its pharmaceutical marketing commitments jeopardizes the 2027 revenue target.
- Sportradar Violations: Sportradar Group AG faces allegations from November 7, 2024, to April 21, 2026, of collaborating with black-market gambling operators, undermining its claims of strict legal compliance and rendering its positive business outlook misleading.
- Commvault Sales Issues: Commvault Systems Inc. is accused of failing to disclose the impact of sales types on its annual recurring revenue (ARR) growth from April 29, 2025, to January 26, 2026, leading to misleading statements about its business prospects.
- Veritone Financial Misconduct: Veritone, Inc. is charged with inaccurately recording and misclassifying revenue from October 14, 2025, to April 14, 2026, necessitating a restatement of financial statements and severely impacting investor confidence in its financial health.
- Legal Investigation Launched: Faruq & Faruqi, LLP is investigating potential securities fraud claims against Veritone, Inc., concerning investor losses incurred between October 14, 2025, and April 14, 2026, urging investors to apply for lead plaintiff status in the class action lawsuit by the July 20, 2026 deadline to protect their legal rights.
- Financial Reporting Errors: Veritone is accused of serious inaccuracies in its financial reporting, including the false recording and misclassification of revenue and costs, which led to significant overstatements of assets, accounts receivable, and comprehensive income, potentially necessitating a restatement of financial statements, thereby undermining investor confidence in the company's financial health.
- Stock Price Volatility: Following the preliminary financial results released on March 26, 2026, where Veritone projected revenues between $18.1 million and $30 million, the stock price plummeted by 29.5% to close at $1.84 per share the next day, exacerbating investor losses and raising concerns about the company's financial stability.
- Subsequent Disclosure Impact: On April 14, 2026, Veritone disclosed that its previously issued financial statements were no longer reliable due to errors, resulting in an 8.3% drop in stock price to $2.09 per share, highlighting severe deficiencies in the company's financial transparency and potentially triggering further legal actions.
- Financial Reporting Errors: Veritone's announcement of Q4 2025 revenue expectations between $18.1 million and $30 million led to a 29.5% stock price drop to $1.84 on March 27, 2026, highlighting investor concerns over financial transparency and accuracy.
- Annual Report Delay: The NT 10-K filed on April 1, 2026, indicated that the company could not timely file its 10-K for FY 2025 due to accounting delays, with expected revenue reductions of $1.5 million to $2.5 million for Q3 2025, exacerbating market fears regarding its financial health.
- Risk of Financial Restatement: The Form 8-K filed on April 14, 2026, revealed significant errors in previously issued financial statements, resulting in overstated revenue and understated net losses, causing an 8.3% stock price decline to $2.09 on April 15, 2026, which reflects declining investor confidence in corporate governance and internal controls.
- Class Action Initiation: Investors are reminded to file lead plaintiff motions by July 20, 2026, alleging that the company failed to disclose material adverse facts about its business and prospects throughout the class period, potentially leading to further losses for investors and indicating significant legal risks for the company's future.











